In today's session, these stocks are experiencing unusual volume.
By Mill Chart
Last update: Sep 19, 2023
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Today's unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| AVGR | 38.36% | 31.24M shares of AVINGER INC (NASDAQ:AVGR) exchanged hands today. Leading to a price increase of 38.36%. This volume is 3.0K% above the average 50 day volume. |
| RDHL | 1.23% | The stock of REDHILL BIOPHARMA LTD-SP ADR (NASDAQ:RDHL) has caught attention with a significant volume of 612.27K shares today. The market is favoring NASDAQ:RDHL today, as its share price records a notable increase of 1.23%. This volume is 34.24% above the average 50 day volume. |
| CATX | -15.57% | 1.7M shares of PERSPECTIVE THERAPEUTICS INC (NYSEARCA:CATX) exchanged hands today. The share price has dropped by 15.57% in today's session. This is 53.11% above the average daily volume of the last 50 days. |
| AVTX | 12.67% | Today, AVALO THERAPEUTICS INC (NASDAQ:AVTX) stands out with a high volume of 74.91M shares. Shares are rising by 12.67%. With an average volume of 30.65M over the past 50 days, the current volume is 144.0% above the average. This deviation signals a potential shift in market dynamics. |
| SHFS | 1.28% | SHF HOLDINGS INC's (NASDAQ:SHFS) traded a high volume of 272.37K shares. NASDAQ:SHFS is experiencing an advancement of 1.28% in its share price today. The average daily volume over the past 50 days is 203.77K. Hence, the current volume is 33.67% above the average volume, indicating a deviation from the usual trading pattern. |
| LOCC | -0.05% | Today's trading session witnessed an unusual volume of 5.57M shares for LIVE OAK CRESTVIEW CLIMATE-A (NYSE:LOCC). Leading to a price decrease of 0.05%. With an average volume of 173.61K over the past 50 days, the current volume is 3.0K% above the average. This deviation signals a potential shift in market dynamics. |
| CMND | -5.56% | The stock of CLEARMIND MEDICINE INC (NASDAQ:CMND) has caught attention with a significant volume of 467.99K shares today. Shares are falling by 5.56%. The average volume over the last 50 days is 341.84K, making today's volume 36.91% above the average. This signifies a notable change in market participation. A press release (Clearmind Medicine Closes US$2.25 Million Public Offering) was released yesterday. |
| VCNX | -6.37% | So far 714.37K shares of VACCINEX INC (NASDAQ:VCNX) have traded in today's session. This decline in share price leads to a decrease of 6.37%. With an average volume of 230.17K over the past 50 days, the current volume is 210.0% above the average. This deviation signals a potential shift in market dynamics. |
| CNXA | 172.0% | The stock of CONNEXA SPORTS TECHNOLOGIES (NASDAQ:CNXA) has caught attention with a significant volume of 363.94M shares today. The share price increased by 172.0%. The current trading volume is 12.0K% above the average 50-day volume. This indicates a significant deviation from the average trading activity. |
| OBIO | 10.66% | ORCHESTRA BIOMED HOLDINGS IN's (NASDAQ:OBIO) traded a high volume of 779.67K shares. Investors in NASDAQ:OBIO are enjoying a price surge of 10.66% today, indicating bullish market sentiment. The current trading volume is 534.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. Earlier today the company had a press release: Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients. |
Our unusual volume stocks screener will show you the full list.
REDHILL BIOPHARMA LTD-SP ADR
NASDAQ:RDHL (9/20/2023, 7:00:02 PM)
After market: 0.79 -0.01 (-1.62%)0.803
+0 (+0.35%)
RDHL News
2 days ago - ChartmillIn today's session, these stocks are experiencing unusual volume.Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
3 days ago - ChartmillGet insights into the top gainers and losers of Monday's pre-market session.As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
3 days ago - RedHill Biopharma Ltd.RedHill Announces FDA sNDA Approval for Talicia®/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, announced the U.S. Food and Drug...
a month ago - RedHill Biopharma Ltd.RedHill Biopharma Provides H1/23 Financial Results and Operational HighlightsRHB-107 included in the U.S. Department of Defense-supported ACESO PROTECT multinational platform trial for early COVID-19 outpatient treatment; The...
2 months ago - RedHill Biopharma Ltd.RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S.RedHill's partner, Gaelan Medical, part of the Ghassan Aboud Group (GAG), receives marketing approval from the United Arab Emirates (UAE) Ministry of Health...
2 months ago - RedHill Biopharma Ltd.RedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDARHB-107 (upamostat) accepted for inclusion in ACESO's PROTECT adaptive platform trial for early COVID-19 outpatient treatment to be conducted in the U.S.,...
2 months ago - RedHill Biopharma LtdRedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant Exercise/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed...
2 months ago - RedHill Biopharma LtdRedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceeds/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered...
